AC
Therapeutic Areas
InterVenn BioSciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Glycoproteomic Signature for Colorectal Neoplasia | Early detection of advanced adenomas and colorectal carcinoma | Discovery/Validation |
| Immunotherapy Response Biomarkers | Predicting response to immune checkpoint inhibitors (e.g., via PD-1 glycosylation) | Discovery |
Leadership Team at InterVenn BioSciences
DC
Dr. Carolyn Bertozzi
Co-Founder, Nobel Laureate
DC
Dr. Carlito Lebrilla
Co-Founder, Distinguished Professor